AR240018A1
(es)
*
|
1987-10-07 |
1990-01-31 |
Merrell Pharma Inc |
Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
|
CN1053570C
(zh)
|
1987-10-07 |
2000-06-21 |
默尔多药物公司 |
哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
|
US4929605A
(en)
*
|
1987-10-07 |
1990-05-29 |
Merrell Dow Pharmaceuticals Inc. |
Pharmaceutical composition for piperidinoalkanol derivatives
|
US4908372A
(en)
*
|
1988-10-13 |
1990-03-13 |
Merrell Dow Pharmaceuticals Inc. |
Antihistaminic piperidinyl benzimidazoles
|
AR245888A1
(es)
*
|
1989-01-23 |
1994-03-30 |
Merrell Pharma Inc |
Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol.
|
DE3917241A1
(de)
*
|
1989-05-26 |
1990-11-29 |
Schaper & Bruemmer Gmbh |
4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
|
US5190029A
(en)
*
|
1991-02-14 |
1993-03-02 |
Virginia Commonwealth University |
Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
US5182097A
(en)
*
|
1991-02-14 |
1993-01-26 |
Virginia Commonwealth University |
Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
TW198008B
(fr)
*
|
1991-04-08 |
1993-01-11 |
Green Cross Corp |
|
HU211019B
(en)
*
|
1991-12-02 |
1995-09-28 |
Richter Gedeon Vegyeszet |
Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
|
CA2129995C
(fr)
*
|
1992-02-13 |
2000-04-11 |
Albert A. Carr |
Derives thiacycliques de piperidinyle
|
US5631375A
(en)
*
|
1992-04-10 |
1997-05-20 |
Merrell Pharmaceuticals, Inc. |
Process for piperidine derivatives
|
MX9302076A
(es)
*
|
1992-04-10 |
1994-03-31 |
Merrell Dow Pharma |
Proceso novedoso para preparar derivados de piperidina.
|
DE69320952T2
(de)
*
|
1992-05-11 |
1999-05-27 |
Merrell Pharmaceuticals Inc., Cincinnati, Ohio |
Verwendung von terfenadin-derivaten als antihistaminika in leberkranken patienten
|
BR9306841A
(pt)
*
|
1992-08-03 |
1998-12-08 |
Sepracor Inc |
Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
|
US5654433A
(en)
*
|
1993-01-26 |
1997-08-05 |
Merrell Pharmaceuticals Inc. |
Process for piperidine derivatives
|
US20020007068A1
(en)
*
|
1999-07-16 |
2002-01-17 |
D'ambra Thomas E. |
Piperidine derivatives and process for their production
|
DK1026147T3
(da)
*
|
1993-06-24 |
2004-03-22 |
Albany Molecular Res Inc |
Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater
|
ES2190442T3
(es)
|
1993-06-25 |
2003-08-01 |
Merrell Pharma Inc |
Nuevos productos intermedios para la preparacion de derivados de 4-difenilmetil/difenilmetoxi piperidina antihistaminicos.
|
US6147216A
(en)
*
|
1993-06-25 |
2000-11-14 |
Merrell Pharmaceuticals Inc. |
Intermediates useful for the preparation of antihistaminic piperidine derivatives
|
WO1995010278A1
(fr)
*
|
1993-10-15 |
1995-04-20 |
Hoechst Marion Roussel, Inc. |
Traitement des troubles allergiques par le carboxylate de terfenadine
|
WO1995011677A1
(fr)
*
|
1993-10-25 |
1995-05-04 |
Merrell Pharmaceuticals Inc. |
Composition pharmaceutique stable a base de terfenadine et d'ibuprofene
|
DE69517810T2
(de)
*
|
1994-05-16 |
2000-12-14 |
Merrell Pharmaceuticals Inc., Cincinnati |
Verfahren und diastereomere salze nützlich bei der racemattrennung von racemischer 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylphenyl essigsäure sowie entsprechende diastereomere salze
|
CN101497581B
(zh)
*
|
1994-05-18 |
2012-07-11 |
安万特萨博Ⅱ有限公司 |
抗组胺哌啶衍生物,其多晶形物和假同晶物的无水和水合物形式的制备方法
|
US20030045722A1
(en)
*
|
1994-05-18 |
2003-03-06 |
Henton Daniel R. |
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
|
ES2176329T3
(es)
*
|
1994-05-18 |
2002-12-01 |
Aventis Pharma Inc |
Procedimientos para preparar formas anhidras e hidratadas de derivados antihistaminicos de piperidina, sus polimeros y pseudomorfos.
|
ES2132709T3
(es)
|
1994-08-25 |
1999-08-16 |
Merrell Pharma Inc |
Nuevas piperidinas substituidas utiles para el tratamiento de las enfermedades alergicas.
|
JP4105762B2
(ja)
*
|
1995-02-28 |
2008-06-25 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
ピペリジノアルカノール化合物のための医薬組成物
|
KR19990008406A
(ko)
*
|
1995-05-08 |
1999-01-25 |
스티븐엘.네스비트 |
알파-(치환된 알킬페닐)-4-(히드록시디페닐메틸)-1-피페리딘 부탄올 유도체들, 그들의 제조 방법 및 항히스타민제, 항알러지제및 기관지 확장제로서 그들의 용도
|
US5574045A
(en)
*
|
1995-06-06 |
1996-11-12 |
Hoechst Marion Roussel, Inc. |
Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
|
US5906747A
(en)
*
|
1995-11-13 |
1999-05-25 |
Biosepra Inc. |
Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
|
US6211199B1
(en)
|
1995-11-17 |
2001-04-03 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
|
US6194406B1
(en)
|
1995-12-20 |
2001-02-27 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
|
US6423704B2
(en)
|
1995-12-20 |
2002-07-23 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
|
US6153754A
(en)
|
1995-12-21 |
2000-11-28 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US6201124B1
(en)
|
1995-12-21 |
2001-03-13 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US5932571A
(en)
*
|
1996-02-21 |
1999-08-03 |
Hoechst Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
|
US5998439A
(en)
*
|
1996-02-21 |
1999-12-07 |
Hoescht Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
|
US5922737A
(en)
*
|
1996-02-21 |
1999-07-13 |
Hoechst Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
|
US5925761A
(en)
*
|
1997-02-04 |
1999-07-20 |
Sepracor Inc. |
Synthesis of terfenadine and derivatives
|
ATE260983T1
(de)
*
|
1997-03-11 |
2004-03-15 |
Aventis Pharma Inc |
Verfahren zur herstellung von 4-(4-(4- (hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl - alpha,alpha-dimenthylphenylessigsäure und phosphorylierter derivate
|
US6451815B1
(en)
|
1997-08-14 |
2002-09-17 |
Aventis Pharmaceuticals Inc. |
Method of enhancing bioavailability of fexofenadine and its derivatives
|
CN1159012C
(zh)
*
|
1997-08-26 |
2004-07-28 |
阿旺蒂斯制药公司 |
用于组合哌啶子基烷醇-减充血剂的药物组合物
|
EP0924196B1
(fr)
*
|
1997-12-17 |
2003-06-18 |
Aventis Pharma Deutschland GmbH |
Procédé pour l'alkylation de nitriles aliphatiques ou benzyliques en présence d'amines ou de phosphines trialkyées
|
ID26390A
(id)
*
|
1997-12-23 |
2000-12-21 |
Schering Corp |
Komposisi untuk pengobatan pernapasan dan penyakit kulit sekurangnya terdiri dari satu leukotrien antagonis dan satu antihistamin
|
US6194431B1
(en)
|
1998-04-14 |
2001-02-27 |
Paul D. Rubin |
Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
|
AU769284B2
(en)
*
|
1998-07-02 |
2004-01-22 |
Aventisub Llc |
Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
AU2007200674C1
(en)
*
|
1998-07-02 |
2011-02-24 |
Aventisub Llc |
Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
US6673933B2
(en)
|
1998-07-02 |
2004-01-06 |
Aventis Pharmaceutical Inc. |
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
US6683094B2
(en)
|
1998-07-02 |
2004-01-27 |
Aventis Pharmaceuticals Inc. |
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
GB9822170D0
(en)
*
|
1998-10-13 |
1998-12-02 |
Danbioyst Uk Ltd |
Novel formulations of fexofenadine
|
IN191492B
(fr)
*
|
1999-05-25 |
2003-12-06 |
Ranbaxy Lab Ltd |
|
US6613906B1
(en)
*
|
2000-06-06 |
2003-09-02 |
Geneva Pharmaceuticals, Inc. |
Crystal modification
|
US6613907B2
(en)
|
2000-11-08 |
2003-09-02 |
Amr Technology, Inc. |
Process for the production of piperidine derivatives with microorganisms
|
CH695216A5
(de)
*
|
2001-02-23 |
2006-01-31 |
Cilag Ag |
Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes.
|
US20030021849A1
(en)
*
|
2001-04-09 |
2003-01-30 |
Ben-Zion Dolitzky |
Polymorphs of fexofenadine hydrochloride
|
IL158334A0
(en)
*
|
2001-04-09 |
2004-05-12 |
Teva Pharma |
Polymorphs of fexofenadine hydrochloride
|
KR20040015734A
(ko)
*
|
2001-06-18 |
2004-02-19 |
닥터 레디스 레보러터리즈 리미티드 |
4-[4-[4-(히드록실디페닐메틸)-1-피페리디닐]-1-히드록시부틸]-α,α-디메틸벤젠 아세트산 및 그 염산염의 신규 결정형태
|
US7700779B2
(en)
|
2001-06-18 |
2010-04-20 |
Dr. Reddy's Laboratories Limited |
Crystalline forms of fexofenadine and its hydrochloride
|
US20030158227A1
(en)
*
|
2001-11-08 |
2003-08-21 |
Barnaba Krochmal |
Polymorphs of fexofenadine base
|
AU2002357701A1
(en)
*
|
2001-11-08 |
2003-05-19 |
Teva Pharmaceutical Industries Ltd. |
Polymorphs of fexofenadine base
|
US6723348B2
(en)
*
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
EP2266590A3
(fr)
|
2002-02-22 |
2011-04-20 |
Shire LLC |
Système d'administration de substances actives et méthodes de protection et d'administration de substances actives
|
EP1474392A1
(fr)
*
|
2002-06-10 |
2004-11-10 |
Teva Pharmaceutical Industries Ltd. |
Forme polymorphe xvi de l'hydrochlorure de fexofenadine
|
CA2510158A1
(fr)
*
|
2002-12-16 |
2004-07-01 |
Ranbaxy Laboratories Limited |
Procede de preparation de la fexofenadine
|
WO2004067511A1
(fr)
*
|
2003-01-31 |
2004-08-12 |
Ranbaxy Laboratories Limited |
Procede de preparation de fexofenadine
|
US20050065183A1
(en)
*
|
2003-07-31 |
2005-03-24 |
Indranil Nandi |
Fexofenadine composition and process for preparing
|
US20050026890A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
|
GB0319935D0
(en)
*
|
2003-08-26 |
2003-09-24 |
Cipla Ltd |
Polymorphs
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
KR20070007196A
(ko)
*
|
2004-04-26 |
2007-01-12 |
테바 파마슈티컬 인더스트리즈 리미티드 |
펙소페나딘 히드로클로라이드의 결정형 및 이의 제조 방법
|
WO2006008567A1
(fr)
*
|
2004-06-18 |
2006-01-26 |
Wockhardt Limited |
Compositions pharmaceutiques a base de composes piperidinoalcanols
|
ITMI20041568A1
(it)
*
|
2004-07-30 |
2004-10-30 |
Dipharma Spa |
"polimorfi di fexofenadina base"
|
US7498345B2
(en)
*
|
2004-09-17 |
2009-03-03 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US7498443B2
(en)
*
|
2004-09-17 |
2009-03-03 |
Albany Molecular Research, Inc. |
Process for production of carebastine
|
US20060148851A1
(en)
*
|
2004-09-28 |
2006-07-06 |
Shlomit Wizel |
Fexofenadine crystal form and processes for its preparation thereof
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
SI2377557T1
(sl)
|
2004-11-24 |
2017-02-28 |
Meda Pharmaceuticals Inc. |
Sestavki, ki obsegajo azelastin, in postopki njihove uporabe
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
JP2008120684A
(ja)
*
|
2005-03-07 |
2008-05-29 |
Kumamoto Univ |
抗アレルギー薬
|
JP5133244B2
(ja)
*
|
2005-08-05 |
2013-01-30 |
ルピン・リミテッド |
フェキソフェナジンの経口用医薬懸濁組成物
|
US20070088065A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jie Du |
Metaxalone products, method of manufacture, and method of use
|
US20080292584A1
(en)
*
|
2005-10-14 |
2008-11-27 |
Mutual Pharmaceutical Company, Inc. |
Metaxalone products, method of manufacture, and method of use
|
WO2007049303A2
(fr)
*
|
2005-10-28 |
2007-05-03 |
Ind-Swift Laboratories Limited |
Procede ameliore pour preparer de la fexofenadine a purete elevee
|
KR20080065704A
(ko)
|
2005-11-09 |
2008-07-14 |
콤비네이토릭스, 인코포레이티드 |
의학적 이상의 치료 방법들, 조성물들, 및 키트들
|
DOP2006000274A
(es)
*
|
2005-12-14 |
2007-10-15 |
Sanofi Aventis Us Llc |
Formulación de suspensión de fexofenadina
|
CN100443470C
(zh)
*
|
2006-07-21 |
2008-12-17 |
杭州保灵有限公司 |
一种依巴斯汀的制备方法
|
ITMI20061491A1
(it)
*
|
2006-07-27 |
2008-01-28 |
Archimica Srl |
Processo per la preparazione di fexofenadina.
|
ITMI20061492A1
(it)
*
|
2006-07-27 |
2008-01-28 |
Archimica Srl |
Processo per la preparazione di fexofenadina.
|
WO2008033466A2
(fr)
*
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions et procédés pour le traitement de maladies virales
|
AU2008287285B2
(en)
|
2007-04-13 |
2013-05-16 |
Southern Research Institute |
Anti-angiogenic agents and methods of use
|
ITMI20070987A1
(it)
*
|
2007-05-16 |
2008-11-17 |
Dipharma Francis Srl |
Procedimento per la preparazione di composti chetonici
|
US20090076080A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched fexofenadine
|
US20090306135A1
(en)
|
2008-03-24 |
2009-12-10 |
Mukesh Kumar Sharma |
Stable amorphous fexofenadine hydrochloride
|
JP2011521948A
(ja)
*
|
2008-05-30 |
2011-07-28 |
フェアフィールド・クリニカル・トライアルズ・リミテッド・ライアビリティ・カンパニー |
皮膚の炎症および変色のための方法ならびに組成物
|
WO2010021681A2
(fr)
*
|
2008-08-18 |
2010-02-25 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions et procédés pour le traitement de maladies virales
|
CN101585805B
(zh)
*
|
2009-06-06 |
2011-07-06 |
浙江大学宁波理工学院 |
一种抗过敏药物非索非那定盐酸盐的制备方法
|
EP2289867A3
(fr)
|
2009-08-19 |
2012-04-25 |
Jubilant Organosys Limited |
Procédé de production d'acide acétique 4-(4-halo-1-oxybutyl)-alpha, alpha-dimethylbenzene ou esthers d'alkyle associés
|
CN101671292B
(zh)
*
|
2009-10-10 |
2011-09-07 |
浙江大学宁波理工学院 |
盐酸非索非那定的合成方法
|
US20110130711A1
(en)
*
|
2009-11-19 |
2011-06-02 |
Follica, Inc. |
Hair growth treatment
|
EP2371817A1
(fr)
*
|
2010-04-01 |
2011-10-05 |
Arevipharma GmbH |
Procédé pour la préparation de 1-[4-(1,1-diméthyléthyl)phényl]-4-[4-(diphénylméthoxy)-1-pipéridinyl]-1-butanone et de sels d'addition acides correspondant
|
US9216955B2
(en)
|
2010-06-15 |
2015-12-22 |
Chemelectiva S.R.L. |
Polymorphic form of Fexofenadine hydrochloride, intermediates and process for its preparation
|
RU2013156864A
(ru)
|
2011-05-23 |
2015-06-27 |
Санофи |
Способ получения дейтерированных соединений, содержащих n-алкильные группы
|
WO2013047725A1
(fr)
|
2011-09-29 |
2013-04-04 |
塩野義製薬株式会社 |
Produit pharmaceutique thérapeutique contre la rhinite allergique comportant un antagoniste de pgd2 et un antagoniste d'histamine
|
EP2578570A1
(fr)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
|
EP2641900A1
(fr)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Nouvelles formes polymorphes de héminapadisylate de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy) hexyl]amino}-1-(R)-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one en tant qu'agoniste du récepteur adrénergique ß2
|
CN102659667B
(zh)
*
|
2012-04-20 |
2013-08-14 |
浙江启明药业有限公司 |
一种非索非那定关键中间体的合成方法
|
CN103333100B
(zh)
*
|
2013-06-06 |
2016-04-06 |
池州东升药业有限公司 |
一种盐酸非索非那定的合成工艺
|
ITMI20131652A1
(it)
|
2013-10-07 |
2015-04-08 |
Dipharma Francis Srl |
Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
|
CN104557671B
(zh)
*
|
2013-10-10 |
2018-04-13 |
池州东升药业有限公司 |
一种非索非那定及中间体的合成方法
|
EP2949321A1
(fr)
|
2014-05-26 |
2015-12-02 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Formulations multicouche de fexofénadine et de montélukast
|
PT3247699T
(pt)
|
2015-01-22 |
2019-08-06 |
Sanofi Aventis Deutschland |
Processo para a produção de 2-[4-(ciclopropanocarbonil)fenil]-2-metil-propanonitrilo
|
PL3365327T3
(pl)
|
2015-10-22 |
2020-05-18 |
Sanofi-Aventis Deutschland Gmbh |
Sposób wytwarzania feksofenadyny i związki pośrednie stosowane w tym sposobie
|
GB202212656D0
(en)
|
2022-08-31 |
2022-10-12 |
Novumgen Ltd |
An orodispersible tablet of fecofenadine and it process of preparation
|